Cardiac Organoids: A 3D Technology for Modeling Heart Development and Disease
- PMID: 35525908
- DOI: 10.1007/s12015-022-10385-1
Cardiac Organoids: A 3D Technology for Modeling Heart Development and Disease
Abstract
Cardiac organoids (COs) are miniaturized and simplified organ structures that can be used in heart development biology, drug screening, disease modeling, and regenerative medicine. This cardiac organoid (CO) model is revolutionizing our perspective on answering major cardiac physiology and pathology issues. Recently, many research groups have reported various methods for modeling the heart in vitro. However, there are differences in methodologies and concepts. In this review, we discuss the recent advances in cardiac organoid technologies derived from human embryonic stem cells (hESCs) and human-induced pluripotent stem cells (hiPSCs), with a focus on the summary of methods for organoid generation. In addition, we introduce CO applications in modeling heart development and cardiovascular diseases and discuss the prospects for and common challenges of CO that still need to be addressed. A detailed understanding of the development of CO will help us design better methods, explore and expand its application in the cardiovascular field.
Keywords: Cardiac Organoids; Cardiac disease models; Engineered heart tissue; Heart development.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Recent Advances in Generation of In Vitro Cardiac Organoids.Int J Mol Sci. 2023 Mar 26;24(7):6244. doi: 10.3390/ijms24076244. Int J Mol Sci. 2023. PMID: 37047216 Free PMC article. Review.
-
Advances in 3D Organoid Models for Stem Cell-Based Cardiac Regeneration.Int J Mol Sci. 2023 Mar 8;24(6):5188. doi: 10.3390/ijms24065188. Int J Mol Sci. 2023. PMID: 36982261 Free PMC article. Review.
-
Advances in cardiac organoid research: implications for cardiovascular disease treatment.Cardiovasc Diabetol. 2025 Jan 18;24(1):25. doi: 10.1186/s12933-025-02598-8. Cardiovasc Diabetol. 2025. PMID: 39827092 Free PMC article. Review.
-
Disease Modeling Using 3D Organoids Derived from Human Induced Pluripotent Stem Cells.Int J Mol Sci. 2018 Mar 21;19(4):936. doi: 10.3390/ijms19040936. Int J Mol Sci. 2018. PMID: 29561796 Free PMC article. Review.
-
Modeling mouse and human development using organoid cultures.Development. 2015 Sep 15;142(18):3113-25. doi: 10.1242/dev.118570. Development. 2015. PMID: 26395140 Review.
Cited by
-
Progress in the Application of Organoids-On-A-Chip in Diseases.Organogenesis. 2024 Dec 31;20(1):2386727. doi: 10.1080/15476278.2024.2386727. Epub 2024 Aug 10. Organogenesis. 2024. PMID: 39126669 Free PMC article. Review.
-
Hypoplastic Left Heart Syndrome: Signaling & Molecular Perspectives, and the Road Ahead.Int J Mol Sci. 2023 Oct 17;24(20):15249. doi: 10.3390/ijms242015249. Int J Mol Sci. 2023. PMID: 37894928 Free PMC article. Review.
-
Extracellular Matrix-Based Approaches in Cardiac Regeneration: Challenges and Opportunities.Int J Mol Sci. 2022 Dec 13;23(24):15783. doi: 10.3390/ijms232415783. Int J Mol Sci. 2022. PMID: 36555424 Free PMC article. Review.
-
circSP199a, a circularized RNA sponge targeting miR-199a-5p and -3p, mitigates mouse cardiac hypertrophy and fibrosis.Acta Pharmacol Sin. 2025 Jul 28. doi: 10.1038/s41401-025-01620-9. Online ahead of print. Acta Pharmacol Sin. 2025. PMID: 40721504
-
The benign nature and rare occurrence of cardiac myxoma as a possible consequence of the limited cardiac proliferative/ regenerative potential: a systematic review.BMC Cancer. 2023 Dec 18;23(1):1245. doi: 10.1186/s12885-023-11723-3. BMC Cancer. 2023. PMID: 38110859 Free PMC article.
References
-
- Voges, H. K., Mills, R. J., Elliott, D. A., et al. (2017). Development of a human cardiac organoid injury model reveals innate regenerative potential [J]. Development, 144(6), 1118–1127. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources